Potrójnie ujemny rak piersi: badanie fazy III leku paclitaxel albumin-bound i sacituzumab tirumotecan
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer…